human-grade tirzepatide (Mounjaro): 22.5% Weight Loss & Dual Agonist MOA Tirzepatide vs. Semaglutide for Weight

Published 2012 Sep 20

Comparing Semaglutide Dose Efficacy and Real-World Outcomes Pivotal trials showed that participants on 2.4 mg weekly semaglutide achieved an average weight loss of 17.4% of baseline body weight over 68 weeks, compared to 3.3% placebo

Glutathione is also an important antioxidant

Multiple Glutathione transferase D and -E ( GstD and GstE ) genes were upregulated at both early and late timepoints with UQCR-C1 knockdown, and some also after wasp infection (Additional File 9: Fig

This is not a prediction of exact medication outcomes but rather a snapshot of your genetic sensitivity across peptide-signaling pathways